Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $62.32 in the prior trading day, Viking Therapeutics Inc (NASDAQ: VKTX) closed at $61.63, down -1.11%. In other words, the price has decreased by -$1.11 from its previous closing price. On the day, 1.82 million shares were traded. VKTX stock price reached its highest trading level at $63.22 during the session, while it also had its lowest trading level at $61.29.
Ratios:
Our goal is to gain a better understanding of VKTX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 37.69 and its Current Ratio is at 37.69. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JP Morgan on September 11, 2024, initiated with a Overweight rating and assigned the stock a target price of $80.
On June 27, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $105.
Raymond James Upgraded its Outperform to Strong Buy on May 16, 2024, whereas the target price for the stock was revised from $115 to $116.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 20 ’24 when SINGLETON J MATTHEW sold 10,300 shares for $69.50 per share. The transaction valued at 715,850 led to the insider holds 9,500 shares of the business.
Lian Brian sold 216,130 shares of VKTX for $15,308,553 on Sep 20 ’24. The President & CEO now owns 2,304,927 shares after completing the transaction at $70.83 per share. On Sep 20 ’24, another insider, Lian Brian, who serves as the Officer of the company, bought 216,130 shares for $18.41 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VKTX now has a Market Capitalization of 6833897472 and an Enterprise Value of 5887206912.
Stock Price History:
Over the past 52 weeks, VKTX has reached a high of $99.41, while it has fallen to a 52-week low of $8.28. The 50-Day Moving Average of the stock is 3.54%, while the 200-Day Moving Average is calculated to be 14.80%.
Shares Statistics:
The stock has traded on average 3.81M shares per day over the past 3-months and 3324890 shares per day over the last 10 days, according to various share statistics. A total of 110.80M shares are outstanding, with a floating share count of 103.66M. Insiders hold about 6.44% of the company’s shares, while institutions hold 73.93% stake in the company. Shares short for VKTX as of 1726185600 were 15906671 with a Short Ratio of 4.18, compared to 1723680000 on 17696767. Therefore, it implies a Short% of Shares Outstanding of 15906671 and a Short% of Float of 19.319999.
